AKT1 and gastric cancer: This suggests that silencing lncTM4SF1-AS1 may lead to downregulated TM4SF1, inhibiting the PI3K/AKT signalling pathway and inhibiting gastric cancer cell invasion, metastasis and the EMT (Fig. 6).